Lecap Asset Management Invests $992K in DaVita

Firm acquires 8,731 shares of dialysis provider's stock in Q4

Apr. 19, 2026 at 11:54am

Got story updates? Submit your updates here. ›

A high-contrast, black and white close-up photograph of the complex machinery and equipment used in a modern dialysis center, conveying the scale and sophistication of DaVita's operations.Lecap Asset Management's investment in dialysis provider DaVita reflects the industry's ongoing appeal to institutional investors.Denver Today

Lecap Asset Management Ltd. acquired a new position in shares of DaVita Inc. (NYSE:DVA) during the fourth quarter, according to the company's recent 13F filing with the Securities & Exchange Commission. The firm purchased 8,731 shares of the company's stock, valued at approximately $992,000.

Why it matters

This investment by Lecap Asset Management in DaVita, a leading provider of kidney care services, highlights the ongoing interest from institutional investors in the dialysis industry. DaVita's business model and growth potential continue to attract attention from the financial community.

The details

Several other hedge funds have also made changes to their positions in DVA. Arrowstreet Capital Limited Partnership boosted its holdings in DaVita by 109.7% during the third quarter, while Neuberger Berman Group LLC increased its stake by 138.5% over the same period. Voloridge Investment Management LLC and Todd Asset Management LLC also added to their DaVita holdings in recent quarters.

  • Lecap Asset Management acquired the DaVita shares in the fourth quarter of 2025.
  • The 13F filing disclosing this investment was published on April 19, 2026.

The players

Lecap Asset Management Ltd.

An investment management firm that acquired a new position in DaVita Inc. during the fourth quarter.

DaVita Inc.

A leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers.

Got photos? Submit your photos here. ›

The takeaway

Lecap Asset Management's investment in DaVita reflects the ongoing institutional interest in the dialysis industry, which continues to attract attention from the financial community due to the company's business model and growth potential.